                </a></li></ul></div><p><strong>Figure 6.  <span>Histological pattern of securin expression in human cancers.</span></strong></p><a id="article1.body1.sec2.sec7.fig1.caption1.p1" name="article1.body1.sec2.sec7.fig1.caption1.p1"></a><p>Representative images of securin expression in human cancer samples.</p>
<a id="article1.body1.sec2.sec7.fig1.caption1.p2" name="article1.body1.sec2.sec7.fig1.caption1.p2"></a><p>Securin expression (brown) is observed in tumor and stromal (arrowheads) cells in (A) late-stage PIN and (C) breast carcinoma <em>in situ</em> tissue sections.</p>
<a id="article1.body1.sec2.sec7.fig1.caption1.p3" name="article1.body1.sec2.sec7.fig1.caption1.p3"></a><p>Invasive cancer stages of (B) prostate, (D) breast, (E) lung, and (F) ovarian cancers show strong securin expression by both tumor and stromal (arrowheads) cells.</p>
<a id="article1.body1.sec2.sec7.fig1.caption1.p4" name="article1.body1.sec2.sec7.fig1.caption1.p4"></a><p>Nuclei were counterstained with haematoxylin.</p>
<a id="article1.body1.sec2.sec7.fig1.caption1.p5" name="article1.body1.sec2.sec7.fig1.caption1.p5"></a><p>Magnification 200Ã—.</p>
<span>THISISTHEEND
